Heidi J. Gray

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

H. Kohrt, J. Berek, A. Secord, 2016, Journal of Immunotherapy for Cancer.

Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial

K. Venkatakrishnan, R. Kurzrock, I. Ray-Coquard, 2019, JAMA oncology.